CROUZON'S SYNDROME: DIFFERENTIAL IN VITRO SECRETION OF bFGF, TGFβ ISOFORMS AND EXTRACELLULAR MATRIX MACROMOLECULES IN PATIENTS WITH FGFR2 GENE MUTATION
- 31 July 2002
- Vol. 19 (2) , 94-101
- https://doi.org/10.1006/cyto.2002.0877
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- A regulatory role of fibroblast growth factor in the expression of decorin, biglycan, betaglycan and syndecan in osteoblasts from patients with Crouzon's syndromeEuropean Journal of Cell Biology, 1999
- Effect of Interleukins on Crouzon Fibroblast Phenotype in vitro. Release of Cytokines and IL-6 mRNA ExpressionCytokine, 1996
- Extracellular matrix synthesized by clonal osteogenic cells is osteoinductive in vivo and in vitro: Role of transforming growth factor-beta1 in osteoblast cell-matrix interactionJournal of Bone and Mineral Research, 1995
- Cell-ECM interactions in developmentSeminars in Developmental Biology, 1995
- Autocrine downregulation of fibroblast growth factor receptors in F9 teratocarcinoma cellsJournal of Cellular Physiology, 1994
- Transforming growth factor β1 is an epithelial-derived signal peptide that influences otic capsule formationDevelopmental Biology, 1992
- Relation between hyaluronan and sulphated glycosaminoglycan synthesis and degradation in cultured embryonic fibroblasts. Effect of concanavalin a and ammonium chloride administrationCell Biochemistry and Function, 1991
- Cytokines in context.The Journal of cell biology, 1991
- Differential expression of genes encoding TGFs β1, β2, and β3 during murine palate formationDevelopmental Biology, 1990
- Fibroblast growth factor enhances type beta 1 transforming growth factor gene expression in osteoblast-like cells.The Journal of cell biology, 1989